|
RASA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
3.462600E-03 |
| Normal-vs-Stage3 |
1.70574665503409E-12 |
| Normal-vs-Stage4 |
4.87040408003736E-11 |
| Stage1-vs-Stage2 |
4.819500E-02 |
| Stage1-vs-Stage3 |
8.501400E-01 |
| Stage1-vs-Stage4 |
8.557800E-01 |
| Stage2-vs-Stage3 |
7.151900E-02 |
| Stage2-vs-Stage4 |
9.913900E-02 |
| Stage3-vs-Stage4 |
9.944400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.221640E-04 |
| Normal-vs-Asian |
4.07360000176382E-08 |
| Caucasian-vs-AfricanAmerican |
8.921600E-01 |
| Caucasian-vs-Asian |
9.828600E-01 |
| AfricanAmerican-vs-Asian |
8.907400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.33757499205012E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
2.482200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
6.97440000196892E-08 |
| Normal-vs-Age(81-100Yrs) |
3.936300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.559900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.226200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.246600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.881800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.909600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.866000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.843000E-01 |
| Classical-VS-Follicular |
1.62458935193399E-12 |
| Classical-VS-Other |
9.586400E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
6.77870004572867E-09 |
| Tall-VS-Other |
9.402600E-01 |
| Tall-VS-Normal |
2.42910025427534E-10 |
| Follicular-VS-Other |
3.265600E-01 |
| Follicular-VS-Normal |
1.490440E-01 |
| Other-VS-Normal |
2.603200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.16382467499443E-12 |
| Normal-vs-N1 |
3.02299996146616E-09 |
| N0-vs-N1 |
3.765800E-02 |
|
|
